BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8251354)

  • 1. In dermographic urticaria H2 receptor antagonists have a small but therapeutically irrelevant additional effect compared with H1 antagonists alone.
    Sharpe GR; Shuster S
    Br J Dermatol; 1993 Nov; 129(5):575-9. PubMed ID: 8251354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of cetirizine on symptoms and wealing in dermographic urticaria.
    Sharpe GR; Shuster S
    Br J Dermatol; 1993 Nov; 129(5):580-3. PubMed ID: 8251355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of H1 and H2 receptor antagonists on the dermographic response.
    Cook J; Shuster S
    Acta Derm Venereol; 1983; 63(3):260-2. PubMed ID: 6192650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic urticaria with terfenadine and ranitidine. A randomized double-blind study in 45 patients.
    Paul E; Bödeker RH
    Eur J Clin Pharmacol; 1986; 31(3):277-80. PubMed ID: 2878811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of urticaria with H1 and H2 antihistaminics. Results of clinical and experimental studies].
    Paul E; Pfeffer M; Bödeker RH
    Z Hautkr; 1987 Mar; 62(5):401-2, 405-6. PubMed ID: 2884788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of cetirizine versus cetirizine plus ranitidine in chronic urticaria: Double-blind randomized placebo-controlled study.
    Guevara-Gutierrez E; Bonilla-Lopez S; Hernández-Arana S; Tlacuilo-Parra A
    J Dermatolog Treat; 2015; 26(6):548-50. PubMed ID: 25886090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial.
    Brockow K; Kiehn M; Riethmüller C; Vieluf D; Berger J; Ring J
    J Allergy Clin Immunol; 1997 Oct; 100(4):458-63. PubMed ID: 9338537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
    Sansom JE; Brooks J; Burton JL; Archer CB
    Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of terfenadine on dermographic wealing.
    Krause LB; Shuster S
    Br J Dermatol; 1984 Jan; 110(1):73-9. PubMed ID: 6419768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of cetirizine and terfenadine in the management of solar urticaria.
    Bilsland D; Ferguson J
    Photodermatol Photoimmunol Photomed; 1991 Apr; 8(2):62-4. PubMed ID: 1684515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results.
    Bagenstose SE; Levin L; Bernstein JA
    J Allergy Clin Immunol; 2004 Jan; 113(1):134-40. PubMed ID: 14713918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria.
    Wan KS
    J Dermatolog Treat; 2009; 20(4):194-7. PubMed ID: 19085267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists.
    Lin RY; Curry A; Pesola GR; Knight RJ; Lee HS; Bakalchuk L; Tenenbaum C; Westfal RE
    Ann Emerg Med; 2000 Nov; 36(5):462-8. PubMed ID: 11054200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the efficacy of cetirizine and terfenadine. A double-blind, controlled study of chronic idiopathic urticaria.
    Andri L; Senna GE; Betteli C; Givanni S; Andri G; Lombardi C; Mezzelani P
    Allergy; 1993 Jul; 48(5):358-65. PubMed ID: 8368464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H1-antagonists hydroxyzine and cetirizine in patients with chronic urticaria.
    Simons FE; Sussman GL; Simons KJ
    J Allergy Clin Immunol; 1995 Mar; 95(3):685-93. PubMed ID: 7897151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Double-blind comparative study of terfenadine and cetirizine in chronic idiopathic urticaria].
    Lambert D; Hantzperg M; Danglas P; Bloom M
    Allerg Immunol (Paris); 1993 Jun; 25(6):235-40. PubMed ID: 8357472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of idiopathic urticaria with H1 + H2 antagonists. A crossover double blind long-term study].
    Diller G; Orfanos CE
    Z Hautkr; 1983 Jun; 58(11):785-93. PubMed ID: 6136132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theophylline as 'add-on' therapy to cetirizine in patients with chronic idiopathic urticaria. A randomized, double-blind, placebo-controlled pilot study.
    Kalogeromitros D; Kempuraj D; Katsarou-Katsari A; Makris M; Gregoriou S; Papaliodis D; Theoharides TC
    Int Arch Allergy Immunol; 2006; 139(3):258-64. PubMed ID: 16449816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effect of cimetidine in chronic-idiopathic urticaria.
    Cook LJ; Shuster S
    Acta Derm Venereol; 1983; 63(3):265-7. PubMed ID: 6192652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine H2-receptor antagonists for urticaria.
    Fedorowicz Z; van Zuuren EJ; Hu N
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD008596. PubMed ID: 22419335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.